You Searched For: Carl Roth GmbH

Catalog Number: (76509-918)

Supplier: Genscript

Description: The product is specific for Obinutuzumab. The antibody is recommended as a capture antibody in a pharmacokinetic (PK) bridging assay with detection antibody GenScript, A01947-40, Anti-Obinutuzumab Antibody (16B7) [Biotin], mAb, Mouse.

Catalog Number: (76510-024)

Supplier: Genscript

Description: MonoRab™ HA tag antibody recognizes HA tags placed at N-terminal, C-terminal, and internal regions of fusion proteins.

Catalog Number: (76509-952)

Supplier: Genscript

Description: The product is specific for Bevacizumab. This antibody blocks Bevacizumab binding with VEGF165 (Z02689, VEGF165, Human). The antibody is recommended as a detection antibody in a pharmacokinetic (PK) bridging assay with capture antibody GenScript, A01895-40, MonoRab Anti-Bevacizumab Antibody (30E1), mAb, Rabbit.

Catalog Number: (77007-522)

Supplier: Genscript

Description: Avelumab with trade name Bavencio, is an FDA-approved drug to treat Merkel cell carcinoma, urothelial carcinoma, and renal cell carcinoma. Avelumab is a whole monoclonal antibody of isotype IgG1 that binds to the programmed death-ligand 1 (PD-L1) and therefore inhibits binding to its receptor programmed cell death 1 (PD-1). PD-L1 can be highly expressed on certain tumors, which is thought to lead to reduced activation of immune cells (cytotoxic T-cells in particular) that might otherwise recognize and attack the cancer. Inhibition of PD-L1 by Avelumab can remove this inhibitor effect and thereby engender an anti-tumor response. It is one of several ways to block inhibitory signals related to T-cell activation, a more general strategy known as 'immune checkpoint inhibition'.Anti-Avelumab Antibody (12G9), mAb, Mouse is produced from a hybridoma resulting from the fusion of partner and B-lymphocytes obtained from a mouse immunized with Avelumab.

Catalog Number: (89494-900)

Supplier: Genscript

Description: GenScript Purified Rabbit IgG (Whole Molecule) Control is highly purified from normal rabbit serum by Protein G chromatography.GenScript Purified Rabbit IgG (Whole Molecule) Control is suitable for use as control, standard, blocking agent, or coating protein in a variety of assays, including ELISA, immunobloting (Dot blot and Western blot), immunoprecipitation, immunodiffusion, and immunoelectrophoresis.It also may be used as antigen or ligand in immunochemical reactions and conjugations.

Catalog Number: (89494-112)

Supplier: Genscript

Description: GenScript Anti-E-tag [HRP] Polyclonal antibody recognizes E tagged fusion proteins.

Catalog Number: (89495-116)

Supplier: Genscript

Description: THE™ V5 Tag antibody [Biotin], mAb, Mouse recognizes N-terminal and C-terminal V5 tagged fusion proteins.

Catalog Number: (76510-100)

Supplier: Genscript

Description: The product is specific for infliximab. The antibody is recommended as a capture antibody in a pharmacokinetic (PK) bridging assay with detection antibody GenScript, A02041-40, anti-infliximab antibody (23H5), mAb, mouse.

Supplier: Genscript

Description: SARS-CoV-2 ADE-causing antibody is a SARS-CoV-2 Spike protein antibody that can exacerbate the COVID-19 disease severity of patients. Antibody-dependent enhancement (ADE) may be involved in the clinical observation of patients with increased severity of symptoms and high levels of SARS-CoV-2 antibodies. It is reported [1] that the same antibodies against the NTD domain of the SARS-CoV-2 spike protein have an ADE effect by increasing the binding of ACE2 to the spike protein.

Supplier: Genscript

Description: SARS-CoV-2 (Severe acute respiratory syndrome coronavirus 2), also known as 2019-nCoV, is a positive-sense single-stranded RNA virus. It caused coronavirus disease in 2019 (COVID-19). SARS-CoV-2 contains glycosylated spike (S) protein, which is composed of S1 subunit and S2 subunit. The S1 contains a receptor-binding domain (RBD) that can bind to ACE2 receptor on target cells. Lineage B.1.351 (a.k.a. 20H/501Y.V2) is a variant of SARS-CoV-2. It has multiple mutations in the RBD, including K417N, E484K, N501Y. Lineage B.1.1.7 (a.k.a. 20I/501Y.V1) is also a variant of SARS-CoV-2 and has a mutation called N501Y in the RBD.SARS-CoV-2 Spike (E484) Neutralizing Antibody (COV2109) is produced from cell culture <i>in vitro</i> under conditions free from animal-derived components. The product is a humanized neutralizing antibody, recognizing E484 site of wild-type RBD. When E484 is mutated to E484K, the mutant RBD, such as RBD (B.1.351) as seen in Figure 1, can’t be recognized by the product.

Supplier: Genscript

Description: The product is specific for SARS-CoV-2 Nucleocapsid protein.

Supplier: Genscript

Description: To enable fast and efficient purification of antibody and epitope-tagged proteins, GenScript provides super paramagnetic magnetic beads. GenScript magnetic beads are coated with recombinant protein ligands that enable highly specific affinity binding to antibodies and epitope-tagged proteins.

Catalog Number: (76510-680)

Supplier: Genscript

Description: This alpha factor pheromone arrests yeast in the G1 phase of their cell cycle. It helps to induces the expression of mating gene, changes in nuclear architecture and consequently polarizes the growth toward the mating partner.

Catalog Number: (76510-540)

Supplier: Genscript

Description: 36053883

Catalog Number: (77007-534)

Supplier: Genscript

Description: Sarilumab with the trade name of Kevzara, is a human monoclonal IgG1 antibody. It binds to membrane bound and soluble interleukin 6 (IL-6) receptor forms. It was FDA-approved in for the treatment of Rheumatoid Arthritis (RA) in combination with methotrexate. GenScript anti-sarilumab antibody, pAb, rabbit is produced from sera of a rabbit immunized with Sarilumab.

Catalog Number: (89495-122)

Supplier: Genscript

Description: THE™ V5 Tag antibody, mAb, Mouse recognizes C-terminal, N-terminal and internal V5 tagged fusion proteins.